Е. А. Дмитриева

Botkin Hospital

H指数:5

被引数:108

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Minimal residual disease–guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype

微小残留病指导下的伊布替尼和维奈克拉在伴有复杂核型的慢性淋巴细胞白血病患者中的应用

British Journal of Haematology

IF3.8

2026-09-050

OAAI

Allogeneic Stem Cell Transplantation—A Salvage Option for High-Risk Chronic Lymphocytic Leukemia Patients: A 15-Year Single-Center Experience

异基因干细胞移植——高风险慢性淋巴细胞白血病患者的一种挽救性选择：一项15年单中心经验

Hematological Oncology

IF3.9

2026-08-200

PRE

Characteristics and 5-year outcomes in patients with chronic lymphocytic leukemia receiving ibrutinib (a real-world study)

慢性淋巴细胞白血病患者接受伊布替尼治疗的特点及5年结果（真实世界研究）

Terapevticheskii Arkhiv

IF0.3

2026-01-010

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病患者的治疗策略和治疗顺序: 欧洲CLL研究计划ERIC的国际研究

HEMASPHERE

IF14.6

2024-09-170

OAAI

Chatzikonstantinou, Thomas; Scarfo, Lydia; Minga, Eva; Karakatsoulis, Georgios; Chamou, Dimitra; Kotaskova, Jana; Iacoboni, Gloria; Demosthenous, Christos; Albi, Elisa; Alcoceba, Miguel; Al-Shemari, Salem; Aurran-Schleinitz, Therese; Bacchiarri, Francesca; Chatzileontiadou, Sofia; Collado, Rosa; Davis, Zadie; de Deus Santos, Marcos Daniel; Dimou, Maria; Dmitrieva, Elena; Donaldson, David; Dos Santos, Gimena; Dreta, Barbara; Efstathopoulou, Maria; El-Ashwah, Shaimaa; Enrico, Alicia; Frygier, Andrzej; Galimberti, Sara; Galitzia, Andrea; Gimeno, Eva; Guarente, Valerio; Guieze, Romain; Harrop, Sean; Hatzimichael, Eleftheria; Herishanu, Yair; Hernandez-Rivas, Jose-angel; Jaksic, Ozren; Kalicinska, Elzbieta; Laribi, Kamel; Karakus, Volkan; Kater, Arnon P.; Kho, Bonnie; Kislova, Maria; Konstantinou, Eliana; Koren-Michowitz, Maya; Kotsianidis, Ioannis; Kubova, Zuzana; Labrador, Jorge; Lad, Deepesh; Laurenti, Luca; Longval, Thomas; Lopez-Garcia, Alberto; Marquet, Juan; Maslejova, Stanislava; Mayor-Bastida, Carlota; Mihaljevic, Biljana; Milosevic, Ivana; Miras, Fatima; Moia, Riccardo; Morawska, Marta; Nath, Uttam K.; Navarro-Bailon, Almudena; Olivieri, Jacopo; Panovska-Stavridis, Irina; Papaioannou, Maria; Pierie, Cheyenne; Puiggros, Anna; Reda, Gianluigi; Rigolin, Gian M.; Ruchlemer, Rosa; Schipani, Mattia; Schiwitza, Annett; Shen, Yandong; Shokralla, Tereza; Simkovic, Martin; Smirnova, Svetlana; Soliman, Dina S. A.; Stilgenbauer, Stephan; Tadmor, Tamar; Tomic, Kristina; Tse, Eric; Vassilakopoulos, Theodoros; Visentin, Andrea; Vitale, Candida; Vrachiolias, George; Vukovic, Vojin; Walewska, Renata; Xu, Zhenshu; Yagci, Munci; Yanez, Lucrecia; Yassin, Mohamed; Zuchnicka, Jana; Oscier, David; Gozzetti, Alessandro; Panagiotidis, Panagiotis; Bosch, Francesc; Sportoletti, Paolo; Espinet, Blanca; Pangalis, Gerassimos A.; Popov, Viola M.; Mulligan, Stephen; Angelopoulou, Maria; Demirkan, Fatih; Papajik, Tomas; Biderman, Bella; Murru, Roberta; Coscia, Marta; Tam, Constantine; Cuneo, Antonio; Gaidano, Gianluca; Claus, Rainer; Stavroyianni, Niki; Trentin, Livio; Antic, Darko; Smolej, Lukas; Kalashnikova, Olga B.; Catherwood, Mark; Spacek, Martin; Pospisilova, Sarka; Doubek, Michael; Nikitin, Eugene; Chatzidimitriou, Anastasia; Ghia, Paolo; Stamatopoulos, Kostas

Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias

LEUKEMIA

IF13.4

2023-05-182

OAAI

Significant reduction in the incidence of non-coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID-19 pandemic: An additional benefit of lockdown

HEMATOLOGICAL ONCOLOGY

IF3.9

2023-04-141

PRE

Platelet function and bleeding in chronic lymphocytic leukemia and mantle cell lymphoma patients on ibrutinib

JOURNAL OF THROMBOSIS AND HAEMOSTASIS